Growth Repression in Diethylstilbestrol/Dimethylbenz[a]anthracene–Induced Rat Mammary Gland Tumor Using Hecate-CGβ Conjugate

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Experimental biology and medicine

• Publication date

  2004-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1177/153537020422900408PMID 15044717
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Human chorionic gonadotropin inhibits proliferation and induces expression of inhibin in human breast epithelial cells in vitro

  2007cited by this paper
• Determination of subcutaneous tumor size in athymic (nude) mice

  2004cited by this paper
• A Novel Approach of Targeted Ablation of Mammary Carcinoma Cells Through Luteinizing Hormone Receptors using Hecate-CGβ Conjugate

  2003cited by this paper
• Membrane Disrupting Lytic Peptide Conjugates Destroy Hormone Dependent and Independent Breast Cancer Cells in vitro and in vivo

  2003cited by this paper
• A Novel Lytic Peptide Composed of dl-Amino Acids Selectively Kills Cancer Cells in Culture and in Mice*

  2003cited by this paper
• Targeted destruction of normal and cancer cells through lutropin/choriogonadotropin receptors using Hecate-betaCG conjugate.

  2003cited by this paper
• Farnesyl transferase inhibitors in the treatment of breast cancer

  2003cited by this paper
• Effects of a lytic peptide conjugated to beta HCG on ovarian cancer: studies in vitro and in vivo.

  2002cited by this paper
• Cancer Statistics, 2001

  2001cited by this paper
• Targeted destruction of androgen‐sensitive and ‐insensitive prostate cancer cells and xenografts through luteinizing hormone receptors

  2001cited by this paper
• Molecular Cloning: A Laboratory Manual

  2001cited by this paper
• Targeted destruction of prostate cancer cells and xenografts by lytic peptide-betaLH conjugates.

  2001cited by this paper
• Loss of alternately spliced messenger RNA of the luteinizing hormone receptor and stability of the follicle-stimulating hormone receptor messenger RNA in granulosa cell tumors of the human ovary.

  2000cited by this paper
• In vitro characterization of the anticancer activity of membrane-active cationic peptides. I. Peptide-mediated cytotoxicity and peptide-enhanced cytotoxic activity of doxorubicin against wild-type and p-glycoprotein over-expressing tumor cell lines.

  2000cited by this paper
• Use of a surrogate marker (human secreted alkaline phosphatase) to monitor in vivo tumor growth and anticancer drug efficacy in ovarian cancer xenografts.

  2000cited by this paper
• Significance of multiple mutations in cancer.

  2000cited by this paper
• Does full-term pregnancy at a young age protect women against breast cancer through hCG?

  2000cited by this paper
• Development of Time-Resolved Immunofluorometric Assays for Rat Follicle-Stimulating Hormone and Luteinizing Hormone and Application on Sera of Cycling Rats

  2000cited by this paper
• Luteinising hormone receptor kinetic and LH-induced prostaglandin production throughout the oestrous cycle in porcine endometrium.

  1999cited by this paper
• Cancer chemotherapy based on targeting of cytotoxic peptide conjugates to their receptors on tumors.

  1999cited by this paper
• No mRNAs for the LH/hCG receptor in human endometrium?

  1999cited by this paper
• Microscopic observations of the different morphological changes caused by anti‐bacterial peptides on Klebsiella pneumoniae and HL‐60 leukemia cells

  1998cited by this paper
• Increased tumors but uncompromised fertility in the female descendants of mice exposed developmentally to diethylstilbestrol.

  1998cited by this paper
• The presence of luteinizing hormone/human chorionic gonadotropin receptors in lactating rat mammary glands.

  1997cited by this paper
• Luteinizing hormone/human chorionic gonadotropin receptors in breast cancer.

  1997cited by this paper
• Presence of functional luteinizing hormone/chorionic gonadotropin (hCG) receptors in human breast cell lines: implications supporting the premise that hCG protects women against breast cancer.

  1997cited by this paper
• Human chorionic gonadotropin‐beta subunit gene expression in cultured human fetal and cancer cells of different types and origins

  1996cited by this paper
• Diethylstilbestrol Revisited: A Review of the Long-Term Health Effects

  1995cited by this paper
• Human chorionic gonadotropin‐beta subunit gene expression in cultured human fetal and cancer cells of different types and origins

  1995cited by this paper
• Multi‐generational carcinogenesis from diethylstilbestrol investigated by blastocyst transfers in mice

  1995cited by this paper
• Targeted approaches to cancer therapy: Meeting held at stone house, NIH, bethesda, md, January 11–12, 1993

  1994cited by this paper
• Ontogeny of luteinizing hormone receptor gene expression in the rat testis.

  1994cited by this paper
• Reproductive factors and breast cancer.

  1993cited by this paper
• Immunolocalization of inhibin in the mammary gland of rats treated with hCG.

  1993cited by this paper
• A supersensitive immunofluorometric assay for rat luteinizing hormone.

  1993cited by this paper
• Is beta-human chorionic gonadotrophin production by transitional cell carcinoma of the bladder a marker of aggressive disease and resistance to radiotherapy?

  1993cited by this paper
• Prolactin as a luteotrophin during late pregnancy in pigs.

  1993cited by this paper
• Novel expression of human chorionic gonadotropin/luteinizing hormone receptor gene in brain.

  1993cited by this paper
• The lutropin/choriogonadotropin receptor ... 4 years later.

  1993cited by this paper
• Beta-hCG expression by bladder cancers.

  1992cited by this paper
• Expression of membrane‐associated human chorionic gonadotropin, its subunits, and fragments by cultured human cancer cells

  1992cited by this paper
• Functional LH receptor appears in the neonatal rat ovary after changes in the alternative splicing pattern of the LH receptor mRNA.

  1992cited by this paper
• Expression of the LH/CG receptor gene in rat ovarian tissue is regulated by an extensive alternative splicing of the primary transcript.

  1992cited by this paper
• Structure of the luteinizing hormone receptor gene and multiple exons of the coding sequence.

  1991cited by this paper
• Comparative study of the influence of pregnancy and hormonal treatment on mammary carcinogenesis.

  1991cited by this paper
• Structural organization of the rat luteinizing hormone (LH) receptor gene.

  1991cited by this paper
• Human chorionic gonadotropin and rat mammary cancer prevention.

  1990cited by this paper
• Cloning of rat lutropin (LH) receptor analogs lacking the soybean lectin domain.

  1990cited by this paper
• Protective effect of chorionic gonadotropin on DMBA-induced mammary carcinogenesis.

  1990cited by this paper
• Intronic nature of the rat luteinizing hormone receptor gene defines a soluble receptor subspecies with hormone binding activity.

  1990cited by this paper
• Structure of the lutropin/choriogonadotropin receptor.

  1990cited by this paper
• Alternative splicing in the control of gene expression.

  1989cited by this paper
• Effect of short-term starvation on reproductive hormone gene expression, secretion and receptor levels in male rats.

  1989cited by this paper
• Cloning and sequencing of porcine LH-hCG receptor cDNA: variants lacking transmembrane domain.

  1989cited by this paper
• Covalent cross-linking of radiolabeled human chorionic gonadotropin to rat ovarian luteinizing hormone receptor with glutaraldehyde.

  1987cited by this paper
• Transplacental action of diethylstilbestrol on mammary carcinogenesis in female rats given one or two doses of 7,12-dimethylbenz(a)anthracene.

  1983cited by this paper
• Transplacental action of diethylstilbestrol on reproductive and endocrine organs, mammary glands, and serum hormone levels in two- and nine-month-old female rats.

  1983cited by this paper
• Morphological and functional consequences of prenatal exposure to diethylstilbestrol in the rat.

  1978cited by this paper
• Follow‐up Study of Male and Female Offspring of DES‐Exposed Mothers

  1977cited by this paper
• Induction of urogenital anomalies and some tumors in the progeny of mice receiving diethylstilbestrol during pregnancy.

  1977cited by this paper
• Structural and functional abnormalities in the sex organs of male offspring of mothers treated with diethylstilbestrol (DES).

  1976cited by this paper
• A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

  1976cited by this paper
• Reproductive tract lesions in male mice exposed prenatally to diethylstilbestrol

  1975cited by this paper

• Melittin Increases Cisplatin Sensitivity and Kills KM-H2 and L-428 Hodgkin Lymphoma Cells

  2020cites this paper
• Targeted Oncolytic Peptide for Treatment of Ovarian

  2017cites this paper
• LH receptor gene expression is essentially absent in breast tumor tissue: implications for treatment.

  2009cites this paper
• Hecate-CGbeta conjugate and gonadotropin suppression shows two distinct mechanisms of action in the treatment of adrenocortical tumors in transgenic mice expressing Simian Virus 40 T antigen under inhibin-alpha promoter.

  2009cites this paper
• Targeted ablation of gonadotropin dependent endocrine tumors in transgenic mice through their luteinizing hormone receptor (LHR)

  2009cites this paper
• Pharmacokinetics and pharmacodynamics of Phor21‐βCG(ala), a lytic peptide conjugate

  2008influential citation
• Immune response to lytic peptides conjugated to a betaCG fragment in treated BALB/C mice.

  2008cites this paper
• Targeted therapy for adrenocortical tumors in transgenic mice through their LH receptor by Hecate-human chorionic gonadotropin beta conjugate.

  2008cites this paper
• Conjugates of lytic peptides and LHRH or βCG target and cause necrosis of prostate cancers and metastases

  2007cites this paper
• Destruction of breast cancers and their metastases by lytic peptide conjugates in vitro and in vivo.

  2007cites this paper
• Therapeutic application of anti-arthritis, pain-releasing, and anti-cancer effects of bee venom and its constituent compounds.

  2007cites this paper
• Novel biological and possible applicable roles of LH/hCG receptor.

  2007cites this paper
• Minireview. Targeting Breast and Prostate Cancers Through Their Hormone Receptors1

  2005cites this paper